The uranium price that pays is in the contract book.

Two prices for the same pound

Cameco sold uranium in the first three months of 2026 for a good deal less than the number on the screen.

The gap is not new. For the whole of 2025 Cameco delivered 33.0 million pounds at a realized US$62.11 per pound (C$87.00), earning C$2,874 million of uranium revenue inside consolidated revenue of C$3,482 million [2]. The industry-average spot price that Cameco publishes from UxC and TradeTech month-ends started 2026 at US$94.28 in January, drifted to US$85.00 by the end of June, and the long-term indicator climbed to US$95.50 over the same months [3]. A reader who priced Cameco off the spot chart in January would have expected revenue the company was never going to book.

How the book is built

Cameco's MD&A describes two families of contract. Base-escalated contracts fix a price that reflects market conditions when the contract was finalized, with escalation applied at delivery. Market-related contracts reference the spot or long-term price, generally set in the month before delivery, and often carry floors and ceilings [1]. The company says it has contracts in place for average annual deliveries of over 28 million pounds a year over the next five years [1], out of long-term commitments of about 230 million pounds in total as of February 2026 [2].

The useful document is the sensitivity table in each quarterly MD&A: for a range of spot prices, what Cameco expects to realize in each of the next five years, with the book as it stands and uncommitted volumes sold at market. The first-quarter 2026 version reads as follows [1].

Expected realized uranium price, US$ per pound, by spot-price case and delivery year. Source: Cameco Q1 2026 MD&A [1]. Management's model, not ours.

Read across the 2026 row first. Between a US$60 and a US$140 spot price, the expected 2026 realized price moves from US$60 to US$69. Nine dollars of realized price for eighty dollars of spot. This year is, for practical purposes, already sold. Now read down the US$100 column: US$67 in 2026, US$74 in 2027, US$79 in 2028, US$85 in 2029, US$87 in 2030 [1]. That is the book rolling off and being replaced, year by year, with contracts that reflect a higher market, if the market is still there.

What 2026 looks like from inside the book

Management's outlook for the year is the book expressed as guidance.

The balance sheet gives management room to be patient about what it signs next: C$1.1 billion of cash and about C$1.0 billion of total debt at March 31, 2026 [1]. The company says it remains selective in committing supply so as to keep exposure to improving market conditions [1]. The uncommitted pounds that would benefit from a higher spot price are the ones Cameco has chosen not to sell yet, and that choice is a bet like any other.

The mill Cameco does not own

A producer's revenue line has a second input besides price, and July 2026 supplied a reminder.

A two-week outage inside a guidance range is not a story. The structure is. Cameco now owns more of a mine whose every pound passes through a partner's plant, and the first disclosure of trouble came from the partner's side of the fence. When a reader models Cigar Lake production, the mill's reliability belongs in the model next to the grade.

NexGen has a licence, not a mine

NexGen is the other end of the same business. It owns a deposit, a licence to build, and cash. It has never sold a pound.

The deposit is unusual. Arrow's probable mineral reserves stand at 240 million pounds of U₃O₈ in 4.6 million tonnes grading 2.37%, within measured and indicated resources (the Canadian NI 43-101 categories, which include the reserves) of 257 million pounds at 3.10% [10]. A reserve is the part of a resource that a feasibility study says can be mined at a profit under stated assumptions. The assumptions are the issue.

Set the numbers side by side: C$655.4 million of cash plus C$362.9 million of short-term investments, against a two-year-old estimate of about C$2.2 billion, with the engineering still moving [10]. Management's statement about funding may rest on cash-flow timing, on debt it has not yet announced, or on a cost it has not yet published. The MD&A does not say which. Until a current capital estimate and a financing plan appear in a filing, the funding of Rook I is a management assertion, and we treat it as one.

The revenue side is clearer, and it rhymes with Cameco in reverse. NexGen signed its first sales contracts in December 2024, 5 million pounds for delivery between 2029 and 2033 to U.S. utilities, and in August 2025 added 1 million pounds a year for five years from the first year of commercial production. Both use market-related pricing mechanisms set at the time of delivery [11][12]. Where Cameco's book lags the market by design, NexGen's book will track it by design. The company is not locking in the current long-term price; it is reserving a place in the queue.

What the two companies share

Both sell into the same reactor fleet against the same price indicators. The difference is who carries the price risk and when. Cameco's shareholders own a smoothed, lagged exposure to the uranium price, funded by two operating mines and a balance sheet with more cash than debt [1]. NexGen's shareholders own a leveraged, delayed exposure to the uranium price of the early 2030s, funded by equity raised in 2025 and convertibles that mature before the mine is finished [10].

What would change our view

For Cameco, a realized price printed above the long-term indicator in a quarterly report, which would mean the book had repriced faster than the table implies, or a Cigar Lake outage that moves the 2026 production range rather than sitting inside it. For NexGen, a published capital estimate dated 2026 with a financing plan attached, or an operating-licence application filed with the CNSC, either of which would turn the funding question from an assertion into arithmetic. Until then, the uranium case for both rests on the contract book, and one of the two companies does not yet have one.